Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Blood Pressure Control of Nifedipine GITS 60mg Treatment in Chinese Hypertensive Subjects Uncontrolled on Starting-dose Mono-therapy: A Prospective, Open-label, Multicenter, Single-arm, 8-week Study.

NCT02413515 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT02413515
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02413515 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Blood Pressure Control of Nifedipine GITS 60mg Treatment in Chinese Hypertensive Subjects Uncontrolled on Starting-dose Mono-therapy: A Prospective, Open-label, Multicenter, Single-arm, 8-week Study.
Lead sponsor
Bayer
Phase
Phase 4
Overall status
Completed
Start date
March 26, 2015
Completion date
August 8, 2016
Enrollment
278 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension